Top stocks in focus on July 3: Nestle India, Aurobindo Pharma, Hindustan Zinc, V2 Retail, CSB Bank and more Stock Market · Jul 3, 2025
Aurobindo Pharma’s subsidiary CuraTeQ Biologics secures marketing approval for trastuzumab biosimilar ‘Dazublys’ Corporates · Jul 2, 2025
Aurobindo Pharma shares fall over 2% after Citi maintains ‘Sell’ rating, cuts target price to Rs 1,100 Stock Market · May 28, 2025
Top stocks to watch today, May 27: Lupin, Aurobindo Pharma, NHPC, KEC International, Shilpa Medicare and more Stock Market · May 27, 2025
Aurobindo Pharma shares drop 3% after company reports fire incident at Kakinada plant Stock Market · Apr 29, 2025
Aurobindo Pharma subsidiary receives positive opinion for biosimilar Dazublys from EMA Corporates · Apr 26, 2025
Aurobindo Pharma receives USFDA approval for Dasatinib Tablets; Stock jumps Corporates · Apr 23, 2025
Aurobindo Pharma subsidiary receives 11 USFDA observations after North Carolina facility inspection Corporates · Apr 11, 2025
Aurobindo Pharma subsidiary secures EU approval for Dyrupeg, a pegylated filgrastim biosimilar Corporates · Apr 5, 2025
Aurobindo Pharma USA’s warehouse receives OAI status with five observations from US FDA Corporates · Feb 20, 2025
Aurobindo Pharma subsidiary’s facility receives EIR from US FDA with VAI classification Corporates · Jan 28, 2025
Aurobindo Pharma subsidiary gets approval for oncology biosimilar Bevqolva from UK’s MHRA Corporates · Dec 21, 2024
Aurobindo Pharma arm Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg Corporates · Dec 5, 2024
Aurobindo Pharma shares surge 2% after on strategic collaboration with global pharma major Stock Market · Nov 25, 2024